WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998001147) MEDICINAL CYCLOSPORIN-A AEROSOL SOLUTION FORMULATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/001147    International Application No.:    PCT/GB1997/001851
Publication Date: 15.01.1998 International Filing Date: 07.07.1997
Chapter 2 Demand Filed:    15.01.1998    
IPC:
A61K 9/12 (2006.01), A61K 38/13 (2006.01)
Applicants: RHONE-POULENC RORER LIMITED [GB/GB]; RPR House, 50 Kings Hill Avenue, Kings Hill, West Malling, Kent ME19 4TA (GB) (For All Designated States Except US).
BELL, Alexander [GB/GB]; (GB) (For US Only)
Inventors: BELL, Alexander; (GB)
Agent: CAFFIN, Lee; Rhone-Poulenc Rorer Limited, Patent Dept., Rainham Road South, Dagenham, Essex RM10 7XS (GB)
Priority Data:
9614326.8 08.07.1996 GB
60/023,048 02.08.1996 US
Title (EN) MEDICINAL CYCLOSPORIN-A AEROSOL SOLUTION FORMULATION
(FR) FORMULATION D'UNE SOLUTION D'AEROSOL MEDICINAL DE CYCLOSPORINE A
Abstract: front page image
(EN)The invention is related to a solution formulation of Cyclosporin A in 1,1,1,2,3,3,3-heptafluoropropane which is suitable for administration to a patient by inhalation using any standard medicinal aerosol device. Standard excipients normally used in medicinal aerosol formulations to aid valve lubrication or improve flavour may also be added. Other medicaments in solution or suspension may be used in addition to Cyclosporin A and other propellants in addition to 1,1,1,2,3,3,3-heptafluoropropane may be used.
(FR)La présente invention porte sur la formulation d'une solution de Cyclosporine A dans un 1,1,1,2,3,3,3-heptafluoropropane, cette formulation pouvant être administrée à un patient par inhalation à l'aide de n'importe quel aérosol médicinal de type classique. A cette formulation, on peut également ajouter des excipients de type classique normalement utilisés dans les formulations d'aérosol médicinal pour aider à la lubrication des valves ou pour améliorer le goût. Outre la Cyclosporine A, on peut ajouter d'autres médicaments à la solution ou à la suspension. On peut également ajouter d'autres propulseurs au 1,1,1,2,3,3,3-heptafluoropropane.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)